FDA
approval
· 2025-10-17
FDA Approved: OZEMPIC — Supplemental Application (Novo Nordisk)
Summary
The FDA approved a supplemental application for Ozempic to include the oral semaglutide formulation, expanding treatment options to patients with type 2 diabete…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for OZEMPIC (ORAL SEMAGLUTIDE)